# Repaglinide (Repaglinide)

Source: https://ourhealthnetwork.com/drugs/repaglinide
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Repaglinide?

Repaglinide is a glinide. It is prescribed to treat diabetes mellitus, type 2. Across the United States, 7,000 doctors prescribe Repaglinide to approximately 35,000 Medicare patients.

## Brand names

Repaglinide

## Indications

Repaglinide is prescribed for the treatment of diabetes mellitus and type 2.

## Conditions treated

- [Diabetes Mellitus](https://ourhealthnetwork.com/conditions/diabetes-mellitus)
- [Type 2](https://ourhealthnetwork.com/conditions/type-2)

## Mechanism of action

Repaglinide lowers blood glucose levels by stimulating the release of insulin from the pancreas. This action is dependent upon functioning beta (ß) cells in the pancreatic islets.

## Drug classification

- Established Pharmacologic Class: Glinide [EPC]
- Mechanism of Action class: Potassium Channel Antagonists [MoA]
- Route of administration: ORAL

## Common side effects

back pain, diarrhea

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)